GNE-9822

Name: GNE-9822
Brand: MedChemExpress
SKU: HY-12410
Rating: 4.5 (1 reviews)

Cat. No.: HY-12410 Purity: 98.47% ee.: 100%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

GNE-9822 is a potent, orally active and selective ITK inhibitor with a K_i value of 0.7 nM, and an EC₅₀ value of 354.5 nM. GNE-9822 has good ADME properties. GNE-9822 can be used in research of asthma.

For research use only. We do not sell to patients.

GNE-9822 Chemical Structure

CAS No. : 1557232-32-2

Size	Stock	Quantity
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	Get quote
100 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

IC₅₀ & Target

EC50: 354.5 nM (ITK)^[2]

Cellular Effect

Cell Line	Type	Value	Description	References
Jurkat	IC₅₀	0.045 μM Compound: 1, GNE-9822	Inhibition of ITK in TCR stimulated human Jurkat T cells assessed as reduction of PLC-gamma phosphorylation preincubated for 30 mins followed by TCR induction for 2 mins Inhibition of ITK in TCR stimulated human Jurkat T cells assessed as reduction of PLC-gamma phosphorylation preincubated for 30 mins followed by TCR induction for 2 mins	[PMID: 25844760]
Jurkat	IC₅₀	4.7 μM Compound: 1, GNE-9822	Cytotoxicity against human Jurkat T cells without TCR stimulation assessed as cell viability by ATPlite assay Cytotoxicity against human Jurkat T cells without TCR stimulation assessed as cell viability by ATPlite assay	[PMID: 25844760]
Jurkat	IC₅₀	55 nM Compound: 28	Inhibition of ITK in human Jurkat cells assessed as reduction in PLC-gamma phosphorylation after 30 mins Inhibition of ITK in human Jurkat cells assessed as reduction in PLC-gamma phosphorylation after 30 mins	[PMID: 24918870]

In Vitro

GNE-9822 (compound 28) inhibits the phosphorylation of PLCγ with an IC₅₀ value of 55 nM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

GNE-9822 (compound 28; po and iv; 1 and 5 mg/kg) has good bioavailability and halflives observed in mouse and rats^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

BALB/c mouse and Sprague-Dawley rats^[1]

Dosage:

1 and 5 mg/kg

Administration:

po (5 mg/kg) and iv (1 mg/kg)

Result:

1.19

species	route	dose volume (mL/kg)	dose (mg/kg)	C_max (μM)	AUC (μM·h)	Cl (mL/min/kg)	T_1/2 (h)	V_ss (L/kg)	%F
mouse (BALB/c)	IV	1.0	1.0		1.5	40	2.9	10
mouse (BALB/c)	PO	5.0	50	3.8	2.7				36

Animal Model:

BALB/c mouse and Sprague-Dawley rats^[1]

Dosage:

1 and 5 mg/kg

Administration:

po (5 mg/kg) and iv (1 mg/kg)

Result:

1.19

species	route	dose volume (mL/kg)	dose (mg/kg)	C_max (μM)	AUC (μM·h)	Cl (mL/min/kg)	T_1/2 (h)	V_ss (L/kg)	%F
rat (Sprague-Dawley	IV	1.0	1.0		0.6	70	3.0	14
rat (Sprague-Dawley	PO	2.0	5.0	0.2	1.1				40

Molecular Weight

420.55

Formula

C₂₄H₃₂N₆O

CAS No.

1557232-32-2

Appearance

Solid

Color

Off-white to light yellow

SMILES

CN(C)CC[C@H](N1N=CC(NC(C2=NNC3=C2CCC(C)(C)C3)=O)=C1)C4=CC=CC=C4

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 62.5 mg/mL (148.61 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.3778 mL	11.8892 mL	23.7784 mL
5 mM	0.4756 mL	2.3778 mL	4.7557 mL
10 mM	0.2378 mL	1.1889 mL	2.3778 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.94 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.94 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (5.94 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 98.47% ee.: 100%

Select Batch:

Data Sheet (279 KB) SDS (251 KB)

COA (252 KB) HNMR (439 KB) RP-HPLC (256 KB) NP-HPLC (332 KB) LCMS (104 KB)

Handling Instructions (2659 KB)

References

[1]. Zhou D, et al. Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity. J Med Chem. 2023 Apr 13;66(7):4979-4998. [Content Brief]

[2]. Burch JD, et, al. Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors. J Med Chem. 2014 Jul 10;57(13):5714-27. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.3778 mL	11.8892 mL	23.7784 mL	59.4460 mL
	5 mM	0.4756 mL	2.3778 mL	4.7557 mL	11.8892 mL
	10 mM	0.2378 mL	1.1889 mL	2.3778 mL	5.9446 mL
	15 mM	0.1585 mL	0.7926 mL	1.5852 mL	3.9631 mL
	20 mM	0.1189 mL	0.5945 mL	1.1889 mL	2.9723 mL
	25 mM	0.0951 mL	0.4756 mL	0.9511 mL	2.3778 mL
	30 mM	0.0793 mL	0.3963 mL	0.7926 mL	1.9815 mL
	40 mM	0.0594 mL	0.2972 mL	0.5945 mL	1.4861 mL
	50 mM	0.0476 mL	0.2378 mL	0.4756 mL	1.1889 mL
	60 mM	0.0396 mL	0.1982 mL	0.3963 mL	0.9908 mL
	80 mM	0.0297 mL	0.1486 mL	0.2972 mL	0.7431 mL
	100 mM	0.0238 mL	0.1189 mL	0.2378 mL	0.5945 mL

GNE-9822 Related Classifications

Inflammation/Immunology

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

GNE-98221557232-32-2GNE9822GNE 9822ItkInterleukin-2 inducible T-cell kinaseIL2 inducible T-cell kinasephosphorylationPLCγbioavailabilityhalflivesorally activeInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Requested Quantity *

Applicant Name *

Salutation

Email Address *

Phone Number *

Department

Organization Name *

City

State

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Email Address *

Phone Number

Department *

Organization Name *

Country or Region *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

GNE-9822

Customer Review

GNE-9822 Related Antibodies

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity

Purity & Documentation

References

Customer Review

GNE-9822 Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

GNE-9822 Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report